A Study of a Multi-Modal Sensor Patch for Real-Time Physiological Monitoring and Inference
NCT05581290 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2024-05-23
Summary
The purpose of this research is to validate the prototype AI-Flex device. Researchers at Mayo Clinic developed a new a flexible multi-modal bio-sensing device, AI-Flex, with integrated artificial intelligence (AI) capability. Integration of sensing and AI analysis on the same device removes the need for data storage on the cloud for later analysis. The goal of the device is to allow real-time monitoring of patient health and timely intervention based on patient health condition. It is hoped that the proposed flexible device will allow intimate skin contact using ultra-thin (\<10 µm) geometry to reduce or eliminate relative movement between the skin and flexible epidermal sensors even during rapid motion of the subject, which would significantly improve the sensor signal quality for AI analysis.
Conditions
- Cardiac Disease
Interventions
- DEVICE
-
AI-Flex
A flexible multi-modal bio-sensing device with integrated AI capability used to measure ECG (heart's electrical activity), body temperature, and PPG (blood volume in tissue); primarly mounted on the wrist and chest.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Imon Banerjee, PhD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-17
- Primary Completion
- 2023-11-17
- Completion
- 2023-11-17
Countries
- United States
Study Locations
More Related Trials
-
Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause
NCT07295769 ·Status: RECRUITING ·Phase: NA
-
Prediction and Maintenance of Sinus Rhythm Among Atrial Fibrillation Patients
NCT04313296 ·Status: TERMINATED ·Phase: NA
-
A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF)
NCT05552963 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation Algorithms Clinical Validation Study
NCT04699812 ·Status: COMPLETED ·Phase: NA
-
Batch Enrollment for AI-Guided Intervention to Lower Neurologic Events in Unrecognized AF
NCT04208971 ·Status: COMPLETED
-
EnSite Precision 2.1 Feasibility Study
NCT03110146 ·Status: COMPLETED
-
FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study
NCT03490201 ·Status: COMPLETED ·Phase: NA
-
The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System
NCT05477602 ·Status: COMPLETED
-
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
NCT06935591 ·Status: RECRUITING ·Phase: NA
-
Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures
NCT07271238 ·Status: RECRUITING ·Phase: NA
-
Performance of Masimo INVSENSOR00057 in Detecting Atrial Fibrillation (Afib)
NCT05472012 ·Status: COMPLETED ·Phase: NA
-
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
NCT07116525 ·Status: RECRUITING ·Phase: NA
-
Feasibility Study of a Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation
NCT02583178 ·Status: UNKNOWN ·Phase: NA
-
ViewFlex X ICE First-in-Human Study
NCT06772493 ·Status: RECRUITING
-
Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm
NCT05458648 ·Status: COMPLETED
-
Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia
NCT02130765 ·Status: TERMINATED ·Phase: NA
-
VitalConnect VitalPatch ECG Interpretation/Arrhythmia Detection
NCT04202718 ·Status: WITHDRAWN ·Phase: NA
-
ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation
NCT02028143 ·Status: COMPLETED ·Phase: NA
-
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
NCT00111488 ·Status: TERMINATED ·Phase: PHASE3
-
Vektor vMap™ Clinical Validation Study
NCT04559061 ·Status: COMPLETED
-
Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection
NCT04076917 ·Status: TERMINATED
-
EnSite Precision Observational Study
NCT03260244 ·Status: COMPLETED
-
Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
NCT02702271 ·Status: COMPLETED ·Phase: NA
-
Post-Embolic Rhythm Detection With Implantable Versus External Monitoring
NCT02428140 ·Status: COMPLETED ·Phase: NA
-
Hybrid Characterization of Driver Sites During Atrial Fibrillation and Sinus Rhythm
NCT05077670 ·Status: UNKNOWN